Sodium-potassium ATPase
Sodium-potassium ATPase | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
EC number | 3.6.3.9 | ||||||||
CAS number | 9001-07-0 | ||||||||
Databases | |||||||||
IntEnz | IntEnz view | ||||||||
BRENDA | BRENDA entry | ||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
Sodium-potassium ATPase (also known as Na⁺/K⁺-ATPase, sodium-potassium pump, and Na⁺/K⁺ pump) is an essential enzyme found in the plasma membrane of all animal cells. It is classified as a P-type ATPase, an enzyme that uses adenosine triphosphate (ATP) to transport ions across cell membranes.
Function[edit | edit source]
The primary function of sodium-potassium ATPase is to regulate the concentrations of sodium (Na⁺) and potassium (K⁺) ions within the cell. This regulation is crucial for maintaining the cell membrane potential, which is vital for neuronal firing, muscle contraction, and various cellular transport processes.
The enzyme operates by pumping three sodium ions out of the cell and two potassium ions into the cell against their concentration gradients, using energy derived from the hydrolysis of ATP. This activity is critical for maintaining the osmotic balance and electrochemical gradient across the cell membrane.
Structure[edit | edit source]
Sodium-potassium ATPase is a heteromeric protein complex composed of multiple subunits:
- The α (alpha) subunit – contains the sites for ATP binding and ion transport.
- The β (beta) subunit – essential for proper folding and membrane localization of the alpha subunit.
- The γ (gamma) subunit – a regulatory subunit, which modulates the activity of the pump.
Clinical Significance[edit | edit source]
Sodium-potassium ATPase plays a significant role in several physiological processes and diseases. It is a target for cardiac glycosides like digoxin and ouabain, which are used in the treatment of heart failure and arrhythmia by increasing the force of heart contraction.
Disruptions in the normal functioning of the Na⁺/K⁺ pump can lead to conditions such as hypertension, epilepsy, and other disorders related to electrolyte imbalance.
Research[edit | edit source]
Research on sodium-potassium ATPase continues to reveal its implications in various health conditions and its potential as a therapeutic target. Studies have explored its role in neurological disorders, cardiovascular diseases, and its interaction with various hormones and drugs.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD